ACTA1 and Hepatic steatosis: Here, opposite to the positive effects of ActA inhibition in chronic liver disease, ActA reduced inflammation, hematopoietic stem cell expansion, liver steatosis, and plasma cholesterol levels while diminishing atherosclerotic lesions (Liu, H. et al., 2023a).